ANXIETY is the #4 most commonly reported adverse reaction for LISDEXAMFETAMINE DIMESYLATE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 1,701 FDA adverse event reports linking LISDEXAMFETAMINE DIMESYLATE to ANXIETY. This represents approximately 2.6% of all 65,887 adverse event reports for this drug.
Patients taking LISDEXAMFETAMINE DIMESYLATE who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
ANXIETY1,701 of 65,887 reports
ANXIETY is a less commonly reported adverse event for LISDEXAMFETAMINE DIMESYLATE, but still significant enough to appear in the safety profile.
Other Side Effects of LISDEXAMFETAMINE DIMESYLATE
In addition to anxiety, the following adverse reactions have been reported for LISDEXAMFETAMINE DIMESYLATE:
ANXIETY has been reported as an adverse event in 1,701 FDA reports for LISDEXAMFETAMINE DIMESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is ANXIETY with LISDEXAMFETAMINE DIMESYLATE?
ANXIETY accounts for approximately 2.6% of all adverse event reports for LISDEXAMFETAMINE DIMESYLATE, making it a notable side effect.
What should I do if I experience ANXIETY while taking LISDEXAMFETAMINE DIMESYLATE?
If you experience anxiety while taking LISDEXAMFETAMINE DIMESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.